Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jude Maghirang"'
Autor:
Heather S. Kirkham, Nishita Hira, Safia Boghani, Glen Pietradoni, Edward A. Witt, Jude Maghirang, Wida S. Cherikh, Amber R. Wilk
Publikováno v:
Journal of Drug Assessment
Background: Though medication adherence is essential for graft survival, non-adherence to immunosuppressants post kidney transplant is common (30–35%), potentially leading to poor quality of life and increased healthcare costs. Aims: The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d087460563bbeafc93d126bf233e21
http://europepmc.org/articles/PMC6764377
http://europepmc.org/articles/PMC6764377
Autor:
H. M. Kauffman, Jude Maghirang, Lode J. Swinnen, Maureen A. McBride, Wida S. Cherikh, Douglas W. Hanto
Publikováno v:
Transplantation. 76:1289-1293
Background. The use of antilymphocyte antibodies for induction therapy or for treatment for rejection has been associated with an increased risk of posttransplant lymphoproliferative disorder (PTLD). The authors investigated the incidence of PTLD aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a808d3f15d844e95cb25da1f60bfefa
https://doi.org/10.1097/01.tp.0000100826.58738.2b
https://doi.org/10.1097/01.tp.0000100826.58738.2b
Autor:
Jude Maghirang, Anthony J. Bleyer, H. Myron Kauffman, Christopher P. Johnson, Wida S. Cherikh
Publikováno v:
Transplantation. 76:463-470
Background. Finding the best combination of immunosuppression is an important challenge in kidney transplantation. Current short-term (1- and 3-year) allograft survival is quite good, making it difficult to determine differences in therapeutic regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8e149c58fb555ad88654e5a9f8b99c
https://doi.org/10.1097/01.tp.0000079839.38844.09
https://doi.org/10.1097/01.tp.0000079839.38844.09
Autor:
Wida S, Cherikh, H M, Kauffman, Maureen A, McBride, Jude, Maghirang, Lode J, Swinnen, Douglas W, Hanto
Publikováno v:
Transplantation. 76(9)
The use of antilymphocyte antibodies for induction therapy or for treatment for rejection has been associated with an increased risk of posttransplant lymphoproliferative disorder (PTLD). The authors investigated the incidence of PTLD after monoclona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dacc724d32cbcceddf988039affd193b
https://pubmed.ncbi.nlm.nih.gov/15446328
https://pubmed.ncbi.nlm.nih.gov/15446328
Publikováno v:
The New England journal of medicine. 345(17)
The effect on allograft survival of the shipment of cadaveric renal allografts from one organ-procurement organization to another is uncertain.Using data from the Organ Procurement and Transplantation Network of the United Network for Organ Sharing,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8345bee054e7c528ef2467d15d61f12a
https://pubmed.ncbi.nlm.nih.gov/11870252
https://pubmed.ncbi.nlm.nih.gov/11870252